Inhaled corticosteroids
Executive Summary
Joint meeting of FDA's Pulmonary-Allergy Drugs and Endocrinologic & Metabolic Drugs Advisory Committees will meet July 30 to discuss the impact of orally inhaled and intranasal corticosteroids on growth in children. On July 31, the committee will consider proposed labeling for the drugs. The meeting begins at 8 a.m. at the Bethesda Marriott...